- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/00 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patent holdings for IPC class C07D 401/00
Total number of patents in this class: 703
10-year publication summary
|
43
|
13
|
17
|
17
|
16
|
10
|
23
|
9
|
21
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3751 |
26 |
| Boehringer Ingelheim International GmbH | 4642 |
19 |
| Bristol-myers Squibb Company | 4880 |
15 |
| Merck Sharp & Dohme Corp. | 2191 |
15 |
| Janssen Pharmaceutica N.V. | 3394 |
15 |
| Vertex Pharmaceuticals Incorporated | 1600 |
14 |
| Takeda Pharmaceutical Company Limited | 2708 |
10 |
| Merck Patent GmbH | 5815 |
9 |
| Abbvie Inc. | 1800 |
9 |
| Theravance Biopharma R&D IP, LLC | 456 |
8 |
| Novartis AG | 10744 |
7 |
| BASF SE | 20940 |
6 |
| Pfizer Inc. | 3371 |
6 |
| Syntrix Biosystems, Inc. | 30 |
6 |
| Universidade Federal do Rio de Janeiro-ufrj | 87 |
6 |
| Sanofi | 4072 |
6 |
| Glaxosmithkline LLC | 537 |
5 |
| Hoffmann-La Roche Inc. | 3439 |
5 |
| Bayer Cropscience AG | 2040 |
5 |
| Amgen Inc. | 4076 |
5 |
| Other owners | 506 |